Arterra Bioscience S.p.A. (BIT:ARBS)

Italy · Delayed Price · Currency is EUR

3.140

-0.060 (-1.88%)

Feb 11, 2026, 4:36 PM CET

64.40% (1Y)

Market Cap	21.31M +64.1%
Revenue (ttm)	4.17M +25.1%
Net Income	1.34M +24.2%
EPS	0.20 +24.2%
Shares Out	6.66M
PE Ratio	15.94
Forward PE	n/a
Dividend	0.13 (4.06%)
Ex-Dividend Date	May 5, 2025

Volume	15,000
Average Volume	44,775
Open	3.100
Previous Close	3.200
Day's Range	3.100 - 3.200
52-Week Range	1.805 - 3.580
Beta	0.88
RSI	43.08
Earnings Date	Mar 30, 2026

About Arterra Bioscience

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2003

Employees 34

Stock Exchange Borsa Italiana

Ticker Symbol ARBS

Full Company Profile

Financial Performance

In 2024, Arterra Bioscience's revenue was 4.17 million, an increase of 25.08% compared to the previous year's 3.34 million. Earnings were 1.34 million, an increase of 24.21%.

Financial Statements